CBIO
Crescent Biopharma Inc.

6,133
Mkt Cap
$295.68M
Volume
205,518.00
52W High
$37.00
52W Low
$9.81
PE Ratio
-0.46
CBIO Fundamentals
Price
$10.15
Prev Close
$10.73
Open
$10.67
50D MA
$12.67
Beta
0.61
Avg. Volume
219,682.82
EPS (Annual)
-$58.75
P/B
1.25
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Guggenheim to Strong-Buy Rating
Guggenheim upgraded Crescent Biopharma to a "strong-buy" rating and set a $35.00 price objective for the company in a research note on Wednesday...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened
Crescent Biopharma (NASDAQ:CBIO) Share Price Crosses Above 200 Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Brokerages
Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have been given a consensus recommendation of "Buy" by the seven brokerages that are currently covering the company, MarketBeat.com...
MarketBeat·2mo ago
News Placeholder
Braidwell LP Invests $4.22 Million in Crescent Biopharma, Inc. $CBIO
Braidwell LP acquired a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange...
MarketBeat·2mo ago
News Placeholder
BVF Inc. IL Makes New Investment in Crescent Biopharma, Inc. $CBIO
BVF Inc. IL purchased a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·2mo ago
News Placeholder
Fairmount Funds Management Llc Purchases 1,360,000 Shares of Crescent Biopharma (NASDAQ:CBIO) Stock
Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) Director Fairmount Funds Management Llc bought 1,360,000 shares of the stock in a transaction on Thursday, December 4th. The shares were...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen downgraded shares of Crescent Biopharma from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·2mo ago
News Placeholder
The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today
Crescent Biopharma announced a strategic partnership with the Chinese firm Sichuan Kelun-Biotech Biopharmaceutical Co. to fast-track its global oncology pipeline.
Stocktwits·2mo ago
News Placeholder
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Analysts
Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) has been given a consensus recommendation of "Buy" by the seven ratings firms that are currently covering the firm, Marketbeat.com reports...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded Crescent Biopharma from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·3mo ago
<
1
2
...
>

Latest CBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.